Veterinary Reference Laboratory Market - By Animal Type (Dogs, Cats, Horses, Cattle, Poultry), By Technology (ELISA, PCR Tests, Hematology), By Application (Pregnancy Testing, Clinical Pathology, Bacteriology), By Region - Global Forecast to 2032

Veterinary Reference Laboratory Market Size

Veterinary Reference Laboratory Market size was valued at around USD 3.9 billion in 2022 and is estimated to reach USD 12.2 billion by 2032. The rising global prevalence of zoonotic illnesses has increased the demand for animal health diagnostics and monitoring services.
 

Zoonotic illnesses are a huge public health issue, particularly in tropical regions that lack adequate healthcare infrastructure and financial resources. Therefore, an increase in consumer awareness pertaining to the importance of investing in the health of animals, particularly those in contact with humans to prevent zoological diseases is expected to fuel the adoption of veterinary diagnostics.
 

A privately held organisation known as a veterinary reference laboratory is responsible for identifying zoonotic diseases in farm and domestic animals. On a regular and specialised basis, the labs are used to test animals for brucellosis, TB, anthrax, yellow fever, rabies, measles, and other diseases. Also, the labs are used to perform check-ups for pre-anaesthetic evaluations and maintain track of treatment outcomes. Veterinary reference laboratory offers services such as clinical pathology, bacteriology, toxicology, virology, and pregnancy testing. They also provide technical and scientific support by using haematology, immunodiagnostics, and molecular diagnostics.

COVID-19 Impact

The coronavirus outbreak proliferated the disease burden and hampered several global businesses including the healthcare sector, during 2020 & initial phase of 2021. This has resulted in delay or postponing several medical and diagnostics procedures. The pandemic disrupted the Research and development activities of veterinary diseases along with the logistics supply of various essential pharmaceutical products for pets.
 

For instance, according to an article published by Frontiers in May 2022, a dog's chronic illness diagnosis, including cancer, reduced the odds of seeking care during the pandemic in UK, reportedly due to difficulties in accessing care for non-urgent issues and lack of access to veterinarians. However, with the declining COVID-19 cases and ease of restrictions, the studied market is expected to regain its full potential over the years.
 

Veterinary Reference Laboratory Market Trends

Rising frequency of zoonotic, transboundary animal diseases (TADs) along with rising adoption of companion animals across the globe are few major factors propelling the market progress. For instance, according to the data published by the European Pet Food Industry: Facts and Figures 2022 report, Germany had 10.3 million dogs and 16.7 million cats in 2021. As per the same source, the percentage of German households owning at least one cat was 21%, and one dog was 19% in 2021. This shows that the adoption of cats was higher among the population than dogs. Thus, factors such as the rising pet adoption, pet insurance and the increasing developments by key market players are expected to boost the market growth. However, rising demand for portable devices for point-of-care (POC) services and high pet care costs are expected to hinder this growth.
 

Veterinary Reference Laboratory Market Analysis

Based on technology, the veterinary reference laboratory market is divided into categories including clinical chemistry, immunodiagnostics, molecular diagnostics, hematology, urinalysis, and other types of technologies. The clinical chemistry technology segment dominated the market in 2022 with a market revenue of USD 1.4 billion. The demand for clinical chemistry analyzers to assess general veterinary health profiles has increased over the past few years, which is contributing to the dominance of this segment. Also, in clinical chemistry tests, the technology involves sample collection, analysis, and consultation. The bodily fluids such as urine & blood are analyzed to evaluate the function & capabilities of the entire metabolism and organs. These parameters offer important information related to disease diagnosing and monitoring. Such benefits associated with clinical chemistry is expected to spur the segment landscape.
 

Based on application, the veterinary reference laboratory market is segmented as bacteriology, virology, clinical pathology, parasitology, pregnancy testing, productivity testing, and toxicology testing. The clinical pathology segment is expected to reach over USD 4.7 billion by 2032. Clinical pathology facilities perform veterinary services including routine blood analysis testing of animals as well as professional consultation for laboratory results. These labs offer coagulation profiles, chemical analysis, complete blood cell counts, blood gas analyses, cross pairing, endocrine testing, urinalysis, and cytology investigations. They also offer veterinary clinical pathologist consulting services.
 

Based on animal type, the veterinary reference laboratory market is segmented as companion animals and livestock animals. The companion animals are further segmented into dogs, cats, horse and other companion animals. The companion animals held a dominant market share in 2022 and is anticipated to grow at 13.4% CAGR between 2023 and 2032. Increase in animal ownership, as various studies indicate that bonding with animals result in health benefits coupled with rising initiatives by the government for animal welfare are few of the major contributing factor for the market development. Also, key industry players are consistently striving to develop differentiated and highly efficacious animal products to create growth prospects for this segment.
 

The North American region held a significant share of the veterinary reference laboratory market accounting for more than 39% in 2022 and is projected to similar trend over the forecast period. Large animal population (especially pets), increasing disease burden, presence of better veterinary care and services and increasing veterinary healthcare are few factors contributing to the regional market expansion.
 

For instance, in September 2022, more than half of Canadian homes (60%) owned at least one dog or cat, according to data from the Canadian Animal Health Institute (CAHI). Similarly, the dog population reached to 7.9 million, while the cat population increased to 8.5 million in 2022. Therefore, owing to larger pet population, the burden of several disease among animals is likely to be higher, thereby driving market size in the region.
 

Veterinary Reference Laboratory Market Leaders

Some of the major market players operating in the veterinary reference laboratory industry are:

• IDEXX Laboratories Inc
• GD Animal Health
• Zoetis Inc.
• NEOGEN Corporation
• LABOKLIN GMBH & CO.KG
• Heska Corporation
• Virbac
• Vaxxinova Gmbh
• Thermo Fisher Scientific Inc
• Boehringer Ingelheim International GmbH
• Colorado State University
• Nova Biomedical,
• Antech Diagnostics, Inc.
   

These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.
 

Veterinary Reference Laboratory Industry News:

• In November 2022, VolitionRx Limited launched its Nu.Q Vet Cancer Screening Test across the U.S. and Europe market through Heska Corporations’ veterinary diagnostic laboratories. This strategy is expected to enhance company’s outreach to untapped economies.
   
• In June 2022, IDEXX Laboratories Inc. launched new reference laboratory tests and services to assist veterinarians acquire insights during wellness screenings, build treatment regimens for cats with chronic renal disease, and receive fast, definite results in the most essential instances.
   

The veterinary reference laboratory market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Technology, 2018 - 2032 (USD Million)

• Clinical Chemistry
• Immunodiagnostics
• ELISA
• Lateral flow assays
• Other immunodiagnostics assa 
• Molecular Diagnostics
• PCR tests
• Microarray
• Other molecular diagnostic services
• Hematology
• Urinalysis
• Other technologies

By Application, 2018 - 2032 (USD Million)

• Clinical Pathology
• Bacteriology
• Virology
• Parasitology
• Productivity Testing
• Pregnancy Testing
• Toxicology Testing

By Animal Type, 2018 - 2032 (USD Million)

• Companion animal
• Dogs
• Cats
• Horses
• Other companion animals 
• Livestock animals
• Cattle
• Swine
• Poultry
• Sheep & goats
• Other livestock animals

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific 
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East & Africa